feed,title,long_url,short_url
Benzinga,Analysts' Varied Perspectives On CytomX's CX-904 Cancer Study: Safety Profile But Caution in Pancreatic Cancer,https://benzinga.com/analyst-ratings/analyst-color/24/05/38741805/analysts-varied-perspectives-on-cytomxs-cx-904-cancer-study-safety-profile-but-caut,https://da.gd/pood4
